The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Huhn Stephen L. since 2024.
This trader's CIK number is 1863904.
At the time of last reporting, Huhn Stephen L. was the CMO & Sr VP, Clinical Dev. of Contineum Therapeutics, Inc.. (stock ticker symbol CTNM).
Also see all insider trading activities at Contineum Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CTNM | 0 | $0 | 0 | $0 | 12,800 | $12,928 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-13 | CTNM | Option Ex | 12,800 | 1.01 | 12,928 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Huhn Stephen L. (CMO & Sr VP, Clinical Dev. of Contineum Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.